lobbying_activities: 2643229
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2643229 | 0a3102c7-a826-489d-ba54-668e74a5cd05 | Q2 | VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC) | 401103475 | CLINICAL REFERENCE LABORATORY, INC. | 2021 | second_quarter | MED | FDA approval process of COVID-19 related medical device and COVID-19 testing solutions. | Food & Drug Administration (FDA),SENATE | 60000 | 0 | 0 | 2021-07-18T14:54:21.513000-04:00 |